Predictors of Remission of Early-Onset Poststroke Depression and the Interaction Between Depression and Cognition During Follow-Up

Objectives: This study aimed to examine the rate of remission in individuals experiencing early-onset poststroke depression (PSD) in China and to identify predictors of remission during a 3-month follow-up. This study also explored the interaction between cognitive impairment and depression. Methods: A total of 820 patients with PSD from a massive multicenter prospective cohort project in China (PRIOD) were included in the present study. Depressive symptoms were measured with the Hamilton Depression Rating Scale (17 Items, HDRS-17) at 2 weeks and the endpoint of the 3-month follow-up. The cut-off score of HDRS-17 ( Results: (1) Six hundred and forty-two patients completed the 3-month follow-up, and 332 (51.7%) patients remitted by the end of the study. Univariate analyses indicated that there was a higher proportion of patients who had hypertension, frontal lobe lesion, basal ganglia lesion, poor outcome at 2 weeks, high scores on the NIHSS at 2 weeks, major life events within 3 months, and major medical diseases within 3 months in the nonremission group. In stepwise multiple logistic regression analyses, remission was significantly predicted by lower NIHSS scores at 2 weeks ( p = 0.001, OR = 1.086, 95% CI 1.035-1.139), fewer major life events ( p = 0.036, OR = 5.195, 95% CI 1.111-27.283), fewer major medical comorbidities ( p = 0.015, OR = 2.434, 95% CI 1.190-4.979), and fewer frontal lobe lesions ( p = 0.042, OR = 1.717, 95% CI 1.019-2.891). (2) After controlling for confounding variables, repeated measures analysis of variance revealed a significant interaction between time (2 weeks vs. 3 months) and group (remitters vs. nonremitters) on MMSE scores [ F (1, 532) = 20.2, p Conclusions: Early-onset PSD patients with milder neurological impairment, fewer major life events, fewer major medical comorbidities and no frontal lobe lesion at baseline were more likely to achieve remission 3 months after stroke. Only remitters of PSD improved significantly in cognitive impairment after stroke. The PRIOD trial is registered at http://www.isrctn.com/, number ISRCTN62169508

Clinical endpoint · Clinical trial · Cohort · Cohort study · Depression (economics · Logistic regression · Multivariate analysis · Physical therapy · Prospective cohort study · Psychiatry · Rating scale · Stroke (engine · Univariate analysis · Acute Ischemic Stroke Management · Dementia and Cognitive Impairment Research · Medicine · Psychology · Stroke Rehabilitation and Recovery · Internal Medicine

• Higher homocysteine and fibrinogen are associated with early-onset post-stroke depression in patients with acute ischemic stroke

  Open Access•Mingzhu Deng, Nina Zhou et al.•Frontiers in Psychiatry•2024

  Incluir item

• Association of atherogenic index of plasma with early-onset post-stroke depression

  Open Access•Mingzhu Deng, Kangping Song et al.•Frontiers in Psychiatry•2025

  Incluir item

• Prevalence, Incidence, and Mortality of Stroke in China

  Wen-Zhi Wang, Wenzhi Wang et al.•Circulation•2017

  Incluir item

• The List of Threatening Experiences

  Open Access•Traolach Brugha, Paul Bebbington et al.•Psychological Medicine•1985

  Incluir item

• Older Adults' Reasons for Using Technology while Aging in Place

  Open Access•Sebastiaan Theodorus Michaël Peek, Katrien Luijkx et al.•Gerontology•2016

  Incluir item

• “Mini-mental state”

  Open Access•Marshal F Folstein, Susan E Folstein et al.•Journal of Psychiatric Research•1975

  Incluir item

• A Rating Scale for Depression

  M Hamilton•Journal of Neurology Neurosurgery…•1960

  Incluir item

• The Association Between Anxiety, Depression, and Somatic Symptoms in a Large Population

  Tone Tangen Haug, Arnstein Mykletun et al.•Psychosomatic Medicine•2004

  Incluir item